Molecular cytogenetic studies of pediatric ependymomas

Journal of Neuro-Oncology

Volumn 37, Issue 1, 1998, Pages 25-33

  Kramer, Deborah L ^a   Parmiter, Annette H ^a   Rorke, Lucy B ^a   Sutton, Leslie N ^a   Biegel, Jaclyn A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Childhood brain tumor; Chromosome 17; Chromosome 22; Chromosome 6; Ependymoma

Indexed keywords

ADOLESCENT; ARTICLE; CANCER GENETICS; CANCER GROWTH; CHILD; CHILDHOOD CANCER; CHROMOSOME 17; CHROMOSOME 17P; CHROMOSOME 22; CHROMOSOME 6; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; EPENDYMOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; KARYOTYPE; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 0031951105     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005925613992     Document Type: Article

References (43)

1. Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J, Deutsch M: Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37: 655-667, 1995
2. Sutton LN, Goldwein J, Perilongo G, Lange BJ, Schut L, Rorke LB, Packer R: Prognostic factors in childhood ependymomas. Pediatr Neurosurg 16: 57-65, 1991
3. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646, 1986
4. Koufos A, Hansen MF, Lampkin BC, Workman ML, Copeland NG, Jenkins NA, Cavenee WK: Loss of alleles at loci on human chromosome 11 during genesis of Wilm's tumor. Nature 309: 170-172, 1984
5. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C: Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J 12: 4481-4487, 1993
6. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, Emanuel BS: Rearrangement of the PAX 3 paired box gene in the pediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet 3: 113-117, 1993
7. Ransom DT, Ritland SR, Kimmel DW, Moertel CA, Dahl RJ, Scheithauer BW, Kelly PJ, Jenkins RB : Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chrom Cancer 5: 348-356, 1992
8. Stratton MD, Darling J, Lantos PL, Cooper CS, Reeves BR: Cytogenetic abnormalities in human ependymomas. Int J Cancer 44: 579-581, 1989
9. James CD, He J, Carlbom E, Mikkelsen T, Ridderheim PA, Cavenee WK, Collins VP: Loss of genetic information in central nervous system tumors common to children and young adults. Genes Chrom Cancer 2: 94-102, 1990
10. Bigner SH, Bigner DD: Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47: 141-154, 1990
11. Griffin CA, LongPP, Carson BS, Brem H: Chromosome abnormalities in low-grade central nervous system tumors. Cancer Genet Cytogenet 60: 67-73, 1992
12. Thiel G, Losanowa T, Kintzel D, Nisch G, Martin H, Vorpahl K, Witkowski R: Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 58: 109-120, 1992
13. Weremowicz SK, Kupsky WJ, Morton CC, Fletcher JA: Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytogenet 61: 193-196, 1992
14. Rogatto SR, Casartelli C, Rainho CA, Barbieri-Neto J: Chromosomes in the genesis and progression of ependymomas. Cancer Genet Cytogenet 69: 146-152, 1993
15. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791-800, 1993
16. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Rouleau GA: The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3: 147-151, 1994
17. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld M, Collins VP, Dumanski JP, Rouleau GA: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Gen 6: 180-184, 1994
18. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delattre JY, Poisson M, Theillet C, Hulsebos T, Delattre O, Thomas G: Predomiant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chrom Cancer 13: 211-216, 1995
19. Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System, fifth edition. Williams and Wilkins, Baltimore, 1989
20. Slave I, MacCollin MM, Dunn M, Jones S, Sutton LN, Gusella JF, Biegel JA: Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Int J Cancer 64: 243-247, 1995
21. von Haken MS, White EC, Daneshvar-Shyesther L, Sih S, Choi E, Kalra R, Cogen PH: Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. Genes Chrom Cancer 17: 37-44, 1996
22. Bijlsma EK, Voesten AMJ, Bijleveld EH, Troost D, Westerveld A, Merel P, Thomas G, Hulsebos TJM: Molecular analysis of genetic changes in ependymomas. Genes Chrom Cancer 13: 272-277, 1995
23. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P: p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202-6205, 1991
24. Metzger AK, Sheffield VC, Duyk G, Daneshvar L, Edwards MSB, Cogen PH: Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. Proc Natl Acad Sci USA 88: 7825-7829, 1991
25. Felix CA, Slave I, Dunn M, Strauss EA, Phillips PC, Rorke LB, Sutton LN, Bunin GR, Biegel JA : p53 gene mutations in pediatric brain tumors. Med Pediatr Oncol 25: 431-436, 1995
26. Fink KL, Rushing EJ, Schold Jr SC, Nisen PD : Infrequency of p53 gene mutations in ependymomas. J Neuro-Oncol 27: 111-115, 1996
27. Cogen PH, Daneshvar L, Metzger AK, Duyk G, Edwards MSB, Sheffield VC: Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet 50: 584-589, 1992
28. Biegel JA, Burk CD, Barr FG, Emanuel BS: Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 52: 3391-3395, 1992
29. Raffel CT, Thomas GA, Tishler DM, Lassoff S, Allen JC: Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery 33: 301-306, 1993
30. Kleihues P, Burger PC, Scheithauer BW: Histologic Typing of Tumours of the Central Nervous System, 1993, Springer, Berlin
31. Biegel JA, Rorke LB, Janss AJ, Sutton LN, Parmiter AH: Isochromosome 17q demonstrated by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system. Genes Chrom Cancer 14: 85-96, 1995
32. Lehrach H et al.: In: Davis KE, Tilghman SM (eds) Genome Analysis Volume I: Genetic and Physical Mapping. Cold Spring Harbor NY: Cold Spring Harbor Laboratory Press 39-81, 1990
33. Biegel JA, Allen CS, Kawasaki K, Shimizu N, Budarf ML, Bell CJ: Narrowing the critical region for a rhabdoid tumor locus in 22q11. Genes Chrom Cancer 16: 94-105, 1996
34. Cooke IE, Shelling AN, Le Meuth VG, Charnock ML, Ganesan TS: Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Genes Chrom Cancer 15: 223-233, 1996
35. Gerken SC, Albertsen H, Eisner T, Ballard L, Holik P, Lawrence E, Moore M, Zhao X, White R: A strategy for constructing high-resolution genetic maps of the human genome: A genetic map of chromosome 17p, ordered with meiotic breakpoint-mapping panels. Am J Hum Genet 56: 484-499, 1995
36. Buetow KH, Duggan D, Yang B, Ludwigsen S, Puck J, Porter J, Budarf M, Spielman R, Emanuel BS: A microsatellitebased multipoint index map of human chromosome 22. Genomics 18: 329-339, 1993
37. Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Goddard K: Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet 71: 40-49, 1993
38. Liang BC, Ross DA, Greenberg HS, Meltzer PS, Trent JM: Evidence of allelic imbalance of chromosome 6 in human astrocytomas. Neurology 44: 533-536, 1994
39. Phelan MC, Stevenson RE, Collins JL, Trent HE: Fragile X Syndrome and Neoplasia. Am J Med Genet 30: 77-82, 1988
40. del Pozo BC, Millard PR: Demonstration of the fra(X) in lymphocytes, fibroblasts, and bone marrow in a patient with a testicular tumor. J Med Genet 20: 225-227, 1983
41. Rodewald L, Miller DC, Sciorra L, Barabas G, Lee M: Central nervous system neoplasm in a young man with Martin-Bell syndrome -fra(X)-XLMR. Am J Med Genet 26: 7-12, 1987
42. Shabtai F, Klar D, Hart J, Halbrecht I: On the meaning of fragile sites in cancer risk and development. Cancer Genet Cytogenet 18: 81-85, 1985
43. Sawyer JR, Sammartino G, Husain M, Boop FA, Chadduck WM: Chromosomal aberrations in four ependymomas. Cancer Genet Cytogenet 74: 132-138, 1994